15 June 2020
https://academic.oup.com/ndt/article/doi/10.1093/ndt/gfaa084/5857810
Midkine and chronic kidney disease–associated multisystem organ dysfunctions
This review summarizes the growing body of evidence supporting MK’s potential role in driving CKD-related multisystem disease, including MK’s relationship with the endothelial glycocalyx, the deranged MK levels and glycocalyx profile in CKD patients and a proposed model of MK organ interplay in CKD disease processes and highlights the importance of ongoing research into MK’s potential as a therapeutic target.
Victoria K Campbell, Ryan P Gately, Rathika Krishnasamy, Dominic Burg, Graham R Robertson, Nicholas A Gray
- Forums
- ASX - By Stock
- Midkine News 2020
15 June...
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1091271 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1258985 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 565639 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
1 | 600000 | 0.003 |
2 | 500000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 80000 | 1 |
0.010 | 157763 | 1 |
0.015 | 340000 | 2 |
0.016 | 100000 | 1 |
0.017 | 110000 | 1 |
Last trade - 16.12pm 02/09/2024 (20 minute delay) ? |
AN1 (ASX) Chart |
Day chart unavailable